Regulation of dopaminergic markers expression in response to acute and chronic morphine and to morphine withdrawal
- 17 December 2014
- journal article
- research article
- Published by Wiley in Addiction Biology
- Vol. 21 (2) , 374-386
Abstract
Dopamine (DA) is thought to represent a teaching signal and has been implicated in the induction of addictive behaviours. Dysfunction of DA homeostasis leading to high or low DA levels is causally linked to addiction. Previously, it has been proposed that the transcription factors Nurr1 and Pitx3, which are critical for transcription of a set of genes involved in DA metabolism in the mesolimbic pathway, are associated with addiction pathology. Using quantitative real‐time polymerase chain reaction, immunofluorescence and Western blotting, we studied the effects of single morphine administration, morphine dependence and withdrawal on the DA markers DA transporters (DAT), vesicular monoamine transporters (VMAT2) and DA 2 receptor subtype (DRD2), DA 1 receptor subtype as well as tyrosine hydroxylase (TH) in the ventral tegmental area (VTA) and/or nucleus accumbens (NAc). In addition, Nurr1 and Pitx3 expression was also measured. Present data showed a high degree of colocalization of Nurr1 and Pitx3 with TH+ neurons in the VTA. We found that the increased Nurr1 and/or Pitx3 levels during morphine dependence and in morphine‐withdrawn rats were associated to an increase of DAT, VMAT2 and DRD2. Altogether, present data indicate that morphine dependence and withdrawal induced consistent alterations of most of the DA markers, which was correlated with transcription factors involved in the maintenance of DA neurons in drug‐reward pathways, suggesting that Nurr1 and Pitx3 regulation might be associated with controlling adaptation to chronic morphine and to morphine withdrawal‐induced alterations of DA neurons activity in the mesolimbic pathway.Keywords
Funding Information
- Ministerio de Ciencia e Imnovación, Spain (SAF/FEDER 2009-07178, SAF/FEDER 2010-17907, SAF/FEDER 2013-49076-P)
- Red de Trastornos Adictivos, Spain (RETICS RD06/0001/1006)
- Fundación Séneca (15405/PI/10)
- Región de Murcia, Spain
- Instituto Murciano de Investigación en Biomedicina (IMIB), Región de Murcia, Spain
- Ministerio de Ciencia e Innovación (AP2009-2379)
This publication has 44 references indexed in Scilit:
- Dysregulation of dopaminergic regulatory mechanisms in the mesolimbic pathway induced by morphine and morphine withdrawalBrain Structure and Function, 2014
- Morphine regulates Argonaute 2 and TH expression and activity but not miR-133b in midbrain dopaminergic neuronsAddiction Biology, 2013
- Morphine administration modulates expression of Argonaute 2 and dopamine‐related transcription factors involved in midbrain dopaminergic neurons functionBritish Journal of Pharmacology, 2012
- Dual Control of Dopamine Synthesis and Release by Presynaptic and Postsynaptic Dopamine D2 ReceptorsThe Journal of Neuroscience, 2012
- Modulation of Striatal Projection Systems by DopamineAnnual Review of Neuroscience, 2011
- VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuseAnnals of the New York Academy of Sciences, 2011
- Dopamine and serotonin transporter availability in chronic heroin users: A [123I]β-CIT SPECT imaging studyPsychiatry Research: Neuroimaging, 2010
- Reward system and addiction: what dopamine does and doesn’t doCurrent Opinion in Pharmacology, 2007
- No Effect of Morphine on Ventral Tegmental Dopamine Neurons during WithdrawalJournal of Neuroscience, 2006
- Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.Proceedings of the National Academy of Sciences, 1988